Francesco Costa
Member of the Editorial Team, PCRonline Editorial Board
Declaration of interest
| Function | Company |
|---|---|
| None |
Latest contributions
Can’t stand heavy metal: how to treat an ACS with severe metal allergy?
17 Mar 2025
Author
Author
Author
Author
No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial
04 Apr 2022
Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
PCRonline @ TCT 2021 - Get the international perspective!
03 Nov 2021
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!
